Pharma Marketing Network

MARCH 20, 2025

The introduction of new drugs, biosimilars, and specialty treatments has led to increased promotional spending. Additionally, privacy regulations such as GDPR and HIPAA are impacting data-driven advertising. Consequently, brands must prioritize digital marketing to reach their target audience effectively.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies HIPAA Biosimilars 59

Pharma Marketing Network

MAY 21, 2025

For example, unbranded resources discussing GLP-1 efficacy or biosimilar adoption trends often outperform product-specific messaging, especially early in the funnel. Use opt-in consent language that aligns with GDPR and HIPAA. AI can assist in targeting and content optimization, but all outputs must be MLR-reviewed and HIPAA-compliant.

HIPAA 52

HIPAA Biosimilars 52

Drug Channels

JULY 11, 2022

Featured Presentations Include : Building a True Hub in Cell Therapy and Specific Disease States End-to-End Launch Excellence Changes to Medicare Part D – Pricing Transparency Panel Problem Solving Copay: Accumulators and Maximizers Embracing Alternative Forms of Interaction with Patients Compliantly HIPAA Enforcement Updates: Best Practices Intersecting (..)

Specialty Pharmacies 98

Specialty Pharmacies HIPAA Biosimilars 98

PharmaShots

FEBRUARY 6, 2023

The app syncs to a HIPAA-compliant, cloud-based patient management portal to facilitate remote patient monitoring and enables physicians to incorporate the Pulse into their clinical workflow.

Health and Personal Care Stores 53

Health and Personal Care Stores Biosimilars HIPAA Pharmaceutical Companies 53

FDA Law Blog: Biosimilars

MAY 26, 2025

Nevertheless, individuals and organizations could be in receipt of grand jury or HIPAA subpoenas requesting records, or they could be visited by federal agents.

Labelling 59

Labelling HIPAA Documentation Immunity 59